// App-Quantinova.ai

POS0125 (2021) : CALCULATING RISK OF HAND OSTEOARTHRITIS PROGRESSION AT TEN YEARS THROUGH A PREDICTION MODEL

Researchers

Presenter

  • K. Shah

Principal Investigators

  • G. Bullock

  • A. Silman

  • D. Furniss

  • N. Arden

  • G. Collins

Medical Centers

  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom

  • University of Oxford, Centre for Sport, Exercise and Osteoarthritis Research, Versus Arthritis, Oxford, United Kingdom

  • University of Oxford, Centre for Rehabilitation Research, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), Oxford, United Kingdom

  • Oxford University Hospitals NHS Trust Biomedical Research Centre, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Genetic Disorder

Disease

  • Osteoarthritis 2

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Merck & Co.

Result

  • N/A